산업동향
Pharmaceutical Industry Profile 2007
- 등록일2007-03-26
- 조회수9566
- 분류산업동향 > 제품 > 바이오의약
-
자료발간일
2007-03-26
-
출처
http://www.phrma.org
-
원문링크
-
키워드
#Pharmaceutical Industry Profile
- 첨부파일
Pharmaceutical Industry Profile 2007
Table of Contents
Introduction
Pharmaceutical Research Companies: Partners in Improving Health. . . . . . . . . . . . . v
Chapter 1
Advancing 21st Century Innovation: More Promise, But More Challenges . . . . . . . . 1
Industry Spending on R&D: Substantial and Growing . . . . . . . . . . . . . . . . . . . . . 2
Creating Safe and Effective New Medicines: The Potential Has Never Been Greater . 2
Today’s R&D Process: Longer, More Complex, and More Costly . . . . . . . . . . . . . . . 3
The Cost of Innovation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
The Research and Development Process . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
Today’s Targets: New Medicines in Development .. . . . . . . . . . . . . . . . . . . . . . 9
Developing Treatments for Rare Diseases. . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
Fostering Innovation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
Strong Patent Incentives and Public/Private Cooperation . . . . . . . . . . . . . . . . . 11
Partners in Innovation: Industry, NIH, Academia . . . . . . . . . . . . . . . . . . . . . . . 12
The Biomarkers Consortium. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
Chapter 2
Expanding Access: Empowering Patients to Get the Medicines They Need . . . . . . 15
Partnership for Prescription Assistance: Free or Nearly Free Medicines for Patients
in Need. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
The Medicare Drug Insurance Program: It’s Working . . . . . . . . . . . . . . . . . . . 17
Direct-to-Consumer Advertising: Empowering Access Through Improved
Patient/Provider Education . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
Chapter 3
Delivering Value: Medicines’ Growing Role in Health Care. . . . . . . . . . . . . . . . . . . . 23
Today’s More Prominent Role for Medicines . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
Medicine’s Share of Health Care Spending Remains Small. . . . . . . . . . . . . . . . . 25
The Value of Medicines: Improving Lives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
The Value of Medicines: Addressing Cost Pressures . . . . . . . . . . . . . . . . . . . . 26
Getting Full Value from Medicines: Improved Adherence Is Key . . . . . . . . . . . . . . 28
Prevention and Wellness Initiative: An Industry/Community Partnership to Fight the
Chronic Disease Crisis. . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
Chapter 4
Helping Those in Need. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
PhRMA Member Philanthropy Continues to Grow. . . . . . . . . . . . . . . . . . . 32
Partnering for Disaster Relief . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
Appendix . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
Member Companies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
PhRMA Annual Membership Survey Definitions of Terms . . . . . . . . . . . . 39
List of Tables: Detailed Results from the PhRMA Annual Membership Survey . . 41
[첨부 파일을 참고하시기 바랍니다]
-
이전글
- The European Federation of Pharmaceutical Industries and Associations
-
다음글
- Biofuels Spark Biotech Rally
관련정보